Tarsus Pharmaceuticals, Inc. GAAP EPS of -$0.48 misses by $0.10, revenue of $102.7M beats by $6.89M

2 hours ago 1

Tarsus Pharmaceuticals, Inc. press release (NASDAQ:TARS): Q2 GAAP EPS of -$0.48 misses by $0.10.
Revenue of $102.7M (+151.7% Y/Y) beats by $6.89M.

Recommended For You